Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMilller Chairman sells over 11m pounds in shares

Tue, 23rd Jul 2013 16:21

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of shares in the company.Mackay sold a total of 350,000 shares between July 16-18th through three separate transactions, the firm revealed on Tuesday. He sold: 138,000 at 3,266.8p each; 50,000 at 3,250.74p each; and another 162,000 at 3,251.4p each.He pocketed £11.4m through the sale, leaving his holding at just over 1.4m shares.The director first joined the beverages company back in 1978 when it was known as South African Breweries and was its Chief Executive Officer (CEO) at the time of its listing in London in 1999. The company was renamed to SABMiller following the purchase of US group Miller Brewing Company in 2002.Mackay was appointed Executive Chairman in July 2012 but, after being diagnosed with a brain tumour in April, the firm accelerated the promotion of Alan Clark to CEO with Mackay taking a more back-seat position of Non-Executive Chairman. At the time of Clark's appointment, the company said it would keep Mackay's position under review until the outcome of his treatment following surgery in April.SABMiller's share price has increased by nearly 16% since the start of 2013.Top Director BuysVerona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 3,000,000 @ 1.67p Value: £50,100Scancell Holdings (SCLP) Director name: Ms Katherine Cornish-BowdenAmount purchased: 45,000 @ 32.00p Value: £14,400Top Director SellsSABMiller (SAB) Director name: Mr Graham MackayAmount sold: 162,000 @ 3,251.40p Value: £5,267,268SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 138,000 @ 3,266.80p Value: £4,508,184SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 50,000 @ 3,250.74p Value: £1,625,370Accsys Technologies (AXS) Director name: Mr Paul Hugh Anthony Clegg Amount sold: 1,500,000 @ € 0.14 Value: € 204,000Accsys Technologies (AXS) Director name: Mr Hans Pauli Amount sold: 330,000 @ € 0.14 Value: € 44,880Accsys Technologies (AXS) Director name: Mr William Bickerton RudgeAmount sold: 119,686 @ € 0.14 Value: € 16,277BC
More News
2 Mar 2018 15:01

BUZZ-Verona Pharma: Soars on positive data from mid-stage study

** British drug developer's U.S.-listed shares up 16 pct at $16.44 in morning trade - second highest gainer amongst Nasdaq-listed companies ** data a

Read more
18 Jan 2017 10:13

Verona Pharma Proposes Share Consolidation Amid Plans To List In US (ALLISS)

Read more
26 Sep 2016 09:39

Verona Pharma appoints sector veteran Morgan as CFO

(ShareCast News) - AIM listed drug development company Verona Pharma appointed sector veteran Piers John Morgan as chief financial officer on Monday, as the company prepares for clinical trials for its flagship drug. Chartered accountant Morgan has 25 years' financial experience and was previously c

Read more
13 Sep 2016 12:04

Verona Pharma makes progress on new respiratory drug

(ShareCast News) - Verona Pharma, a UK based drug development company focused on first-in-class medicines to treat respiratory diseases, reported positive results on new drug "RPL554". The company's lead drug, RPL554, is a first-in-class drug currently in Phase 2 trials as a nebulized maintenance tr

Read more
20 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
20 Jun 2016 12:50

Verona Pharma secures funding for drug trial

(ShareCast News) - Shares in AIM-listed Verona Pharma rallied on Monday as the drug development company it had successfully secured funding commitments to raise gross proceeds of around £44.7m through a conditional placing that was significantly oversubscribed. Net proceeds from the placing with new

Read more
20 Jun 2016 11:06

LONDON MARKET MIDDAY: Receding Brexit Fear Lifts Stocks And Pound

Read more
20 Jun 2016 09:40

WINNERS & LOSERS SUMMARY: Cat Allergy Disappointment Sinks Circassia

Read more
17 Jun 2016 16:09

Verona Pharma To Raise GBP44.7 Million In Share Placing (ALLIS)

Read more
3 Jun 2016 12:52

Verona Pharma's shares fall as higher R&D costs widen FY loss

(ShareCast News) - Shares in Verona Pharma sagged more than 8% as it turned in a wider full-year pre-tax loss of £8.9m, from a loss of £3.8m, thanks to higher research and development more than doubling. Chief executive Jan-Anders Karlsson said Verona had made substantial clinical progress with its

Read more
3 Jun 2016 06:59

Verona Pharma Loss Widens On Higher Research And Development Costs

Read more
10 May 2016 08:11

Verona Pharma Gets Positive Results From COPD Treatment Study

Read more
15 Mar 2016 10:35

Verona Pharma excites with asthma trial results

(ShareCast News) - Verona Pharma has published further encouraging clinical results for its RPL554 drug to treat chronic obstructive pulmonary disorder (COPD). Tests among asthma patients found the inhaled drug, which has both bronchodilator and anti-inflammatory properties in the same active molecu

Read more
21 Jan 2016 13:31

DIRECTOR DEALINGS: Verona Pharma Chairman Ups Interest

Read more
11 Jan 2016 08:45

Verona Pharma Chief Financial Officer Biresh Roy Leaving Company

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.